Request for Covid-19 Impact Assessment of this Report
The United States Prothrombin Complex Concentrate (PCC) Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Prothrombin Complex Concentrate (PCC) Drug market, reaching US$ million by the year 2028. As for the Europe Prothrombin Complex Concentrate (PCC) Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Prothrombin Complex Concentrate (PCC) Drug players cover Takeda, CSL Behring GmbH, Grifols Biologicals, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Prothrombin Complex Concentrate (PCC) Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hemophilia B
Vitamin K Deficiency
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Takeda
CSL Behring GmbH
Grifols Biologicals
Octapharma
Hualan Biological
Meheco Xinxing Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Prothrombin Complex Concentrate (PCC) Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Prothrombin Complex Concentrate (PCC) Drug by Country/Region, 2017, 2022 & 2028
2.2 Prothrombin Complex Concentrate (PCC) Drug Segment by Type
2.2.1 500 IU/Vial
2.2.2 600 IU/Vial
2.2.3 1000 IU/Vial
2.2.4 Others
2.3 Prothrombin Complex Concentrate (PCC) Drug Sales by Type
2.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Type (2017-2022)
2.4 Prothrombin Complex Concentrate (PCC) Drug Segment by Application
2.4.1 Hemophilia B
2.4.2 Vitamin K Deficiency
2.4.3 Others
2.5 Prothrombin Complex Concentrate (PCC) Drug Sales by Application
2.5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Application (2017-2022)
3 Global Prothrombin Complex Concentrate (PCC) Drug by Company
3.1 Global Prothrombin Complex Concentrate (PCC) Drug Breakdown Data by Company
3.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Annual Sales by Company (2020-2022)
3.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Company (2020-2022)
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2022)
3.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Company (2020-2022)
3.3 Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Company
3.4 Key Manufacturers Prothrombin Complex Concentrate (PCC) Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prothrombin Complex Concentrate (PCC) Drug Product Location Distribution
3.4.2 Players Prothrombin Complex Concentrate (PCC) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Prothrombin Complex Concentrate (PCC) Drug by Geographic Region
4.1 World Historic Prothrombin Complex Concentrate (PCC) Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Annual Revenue by Geographic Region
4.2 World Historic Prothrombin Complex Concentrate (PCC) Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Annual Revenue by Country/Region
4.3 Americas Prothrombin Complex Concentrate (PCC) Drug Sales Growth
4.4 APAC Prothrombin Complex Concentrate (PCC) Drug Sales Growth
4.5 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Growth
4.6 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Growth
5 Americas
5.1 Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Country
5.1.1 Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022)
5.1.2 Americas Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022)
5.2 Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Type
5.3 Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Region
6.1.1 APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2017-2022)
6.1.2 APAC Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2017-2022)
6.2 APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Type
6.3 APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Prothrombin Complex Concentrate (PCC) Drug by Country
7.1.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022)
7.1.2 Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022)
7.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Type
7.3 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug by Country
8.1.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Type
8.3 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prothrombin Complex Concentrate (PCC) Drug
10.3 Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug
10.4 Industry Chain Structure of Prothrombin Complex Concentrate (PCC) Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prothrombin Complex Concentrate (PCC) Drug Distributors
11.3 Prothrombin Complex Concentrate (PCC) Drug Customer
12 World Forecast Review for Prothrombin Complex Concentrate (PCC) Drug by Geographic Region
12.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Region
12.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Forecast by Region (2023-2028)
12.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prothrombin Complex Concentrate (PCC) Drug Forecast by Type
12.7 Global Prothrombin Complex Concentrate (PCC) Drug Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Offered
13.1.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL Behring GmbH
13.2.1 CSL Behring GmbH Company Information
13.2.2 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Product Offered
13.2.3 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Behring GmbH Main Business Overview
13.2.5 CSL Behring GmbH Latest Developments
13.3 Grifols Biologicals
13.3.1 Grifols Biologicals Company Information
13.3.2 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Product Offered
13.3.3 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Grifols Biologicals Main Business Overview
13.3.5 Grifols Biologicals Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Offered
13.4.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Hualan Biological
13.5.1 Hualan Biological Company Information
13.5.2 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Product Offered
13.5.3 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hualan Biological Main Business Overview
13.5.5 Hualan Biological Latest Developments
13.6 Meheco Xinxing Pharma
13.6.1 Meheco Xinxing Pharma Company Information
13.6.2 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Product Offered
13.6.3 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Meheco Xinxing Pharma Main Business Overview
13.6.5 Meheco Xinxing Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Prothrombin Complex Concentrate (PCC) Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Prothrombin Complex Concentrate (PCC) Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 500 IU/Vial
Table 4. Major Players of 600 IU/Vial
Table 5. Major Players of 1000 IU/Vial
Table 6. Major Players of Others
Table 7. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
Table 8. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)
Table 9. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & ($ million)
Table 10. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2022)
Table 11. Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
Table 13. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)
Table 14. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022)
Table 15. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2022)
Table 16. Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Company (2020-2022) & (K Units)
Table 18. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Company (2020-2022)
Table 19. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Company (2020-2022)
Table 21. Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Prothrombin Complex Concentrate (PCC) Drug Producing Area Distribution and Sales Area
Table 23. Players Prothrombin Complex Concentrate (PCC) Drug Products Offered
Table 24. Prothrombin Complex Concentrate (PCC) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share Geographic Region (2017-2022)
Table 29. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country/Region (2017-2022)
Table 33. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022) & (K Units)
Table 36. Americas Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2017-2022)
Table 37. Americas Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2017-2022)
Table 39. Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
Table 40. Americas Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)
Table 41. Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
Table 42. Americas Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)
Table 43. APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2017-2022) & (K Units)
Table 44. APAC Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2017-2022)
Table 45. APAC Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2017-2022)
Table 47. APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
Table 48. APAC Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)
Table 49. APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
Table 50. APAC Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)
Table 51. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022) & (K Units)
Table 52. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2017-2022)
Table 53. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2017-2022)
Table 55. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
Table 56. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)
Table 57. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
Table 58. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Prothrombin Complex Concentrate (PCC) Drug
Table 68. Key Market Challenges & Risks of Prothrombin Complex Concentrate (PCC) Drug
Table 69. Key Industry Trends of Prothrombin Complex Concentrate (PCC) Drug
Table 70. Prothrombin Complex Concentrate (PCC) Drug Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Prothrombin Complex Concentrate (PCC) Drug Distributors List
Table 73. Prothrombin Complex Concentrate (PCC) Drug Customer List
Table 74. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Forecast by Region
Table 76. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share Forecast by Application (2023-2028)
Table 94. Takeda Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Takeda Prothrombin Complex Concentrate (PCC) Drug Product Offered
Table 96. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Takeda Main Business
Table 98. Takeda Latest Developments
Table 99. CSL Behring GmbH Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Product Offered
Table 101. CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. CSL Behring GmbH Main Business
Table 103. CSL Behring GmbH Latest Developments
Table 104. Grifols Biologicals Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Product Offered
Table 106. Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Grifols Biologicals Main Business
Table 108. Grifols Biologicals Latest Developments
Table 109. Octapharma Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Offered
Table 111. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Octapharma Main Business
Table 113. Octapharma Latest Developments
Table 114. Hualan Biological Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Product Offered
Table 116. Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Hualan Biological Main Business
Table 118. Hualan Biological Latest Developments
Table 119. Meheco Xinxing Pharma Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Product Offered
Table 121. Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Meheco Xinxing Pharma Main Business
Table 123. Meheco Xinxing Pharma Latest Developments
List of Figures
Figure 1. Picture of Prothrombin Complex Concentrate (PCC) Drug
Figure 2. Prothrombin Complex Concentrate (PCC) Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prothrombin Complex Concentrate (PCC) Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 500 IU/Vial
Figure 10. Product Picture of 600 IU/Vial
Figure 11. Product Picture of 1000 IU/Vial
Figure 12. Product Picture of Others
Figure 13. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type in 2021
Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2022)
Figure 15. Prothrombin Complex Concentrate (PCC) Drug Consumed in Hemophilia B
Figure 16. Global Prothrombin Complex Concentrate (PCC) Drug Market: Hemophilia B (2017-2022) & (K Units)
Figure 17. Prothrombin Complex Concentrate (PCC) Drug Consumed in Vitamin K Deficiency
Figure 18. Global Prothrombin Complex Concentrate (PCC) Drug Market: Vitamin K Deficiency (2017-2022) & (K Units)
Figure 19. Prothrombin Complex Concentrate (PCC) Drug Consumed in Others
Figure 20. Global Prothrombin Complex Concentrate (PCC) Drug Market: Others (2017-2022) & (K Units)
Figure 21. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)
Figure 22. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application in 2021
Figure 23. Prothrombin Complex Concentrate (PCC) Drug Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Company in 2021
Figure 25. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Geographic Region in 2021
Figure 27. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2017-2022)
Figure 28. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country/Region in 2021
Figure 29. Americas Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2022 (K Units)
Figure 30. Americas Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2022 ($ Millions)
Figure 31. APAC Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2022 (K Units)
Figure 32. APAC Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2022 ($ Millions)
Figure 33. Europe Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2022 (K Units)
Figure 34. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2022 ($ Millions)
Figure 37. Americas Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2021
Figure 38. Americas Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country in 2021
Figure 39. United States Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region in 2021
Figure 44. APAC Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Regions in 2021
Figure 45. China Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2021
Figure 52. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country in 2021
Figure 53. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country in 2021
Figure 60. Egypt Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Prothrombin Complex Concentrate (PCC) Drug in 2021
Figure 66. Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug
Figure 67. Industry Chain Structure of Prothrombin Complex Concentrate (PCC) Drug
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...